Actively Recruiting
Local Registry for Data Collection of Patients With Achondroplasia / Hypochondroplasia for Epidemiological, Care and Research Studies
Led by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Updated on 2022-04-28
200
Participants Needed
1
Research Sites
261 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are collecting clinical data from patients diagnosed with achondroplasia and hypochondroplasia through an observational registry study. This study aims to gather information to support epidemiological research, care improvements, and scientific studies related to these conditions. The registry is managed by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico and will continue for at least 10 years. The study involves enrolling patients with confirmed diagnoses of achondroplasia or hypochondroplasia. There are no specific interventions or treatments given as part of this study, as it is observational and focuses on data collection only. Participants are registered and their health data is recorded and monitored over time to aid research and care. Participants will provide informed consent, and their clinical information will be collected and stored in the registry for up to 10 years. The primary outcome measure is the establishment and maintenance of a registry for these patients. There are no experimental procedures; instead, patient data is reviewed to understand disease characteristics and outcomes better. This long-term data collection helps researchers and clinicians improve understanding and management of achondroplasia and hypochondroplasia.
CONDITIONS
Brief Title
Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of achondroplasia or hypochondroplasia
- Patients or their legal guardians able to provide informed consent
You will not qualify if you...
- No diagnosis of achondroplasia or hypochondroplasia
- Patients or their legal guardians unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants who undergo routine care are observed. Measurements are collected before and after routine healthcare.
Visits scheduled according to routine care
Trial Site Locations
Total: 1 location
1
Medical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan
Milan, Italy, 20122
Actively Recruiting
Research Team
M
Maria Francesca Bedeschi, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here